On March 26, Xu Zifu, deputy director of the Zhejiang Branch of the State Administration of Foreign Exchange, and his entourage visited our company for inspection and guidance, investigating our company’s resumption of work and production, production and operation (including issues and needs in foreign exchange policies, etc.), relevant municipal and county departments The leader accompanied the investigation and the company’s chairman Hu Jinsheng personally received it.

At the meeting, Chairman Hu Jinsheng introduced the company's main products, production capacity, local subsidiaries, foreign exchange settlement, R&D team, and product development. Hu Jinsheng said that the current new crown pneumonia epidemic has indeed had a certain impact on the company’s production and operation, but overall the impact is not significant; the two products produced by the company (contrast agent series products and levoxon series products) are useful for the fight against the epidemic. Help; the company's goal is to compete with foreign original research units, fill up the domestic gap, and contribute to the health of mankind.

After listening to Hu Jinsheng's report, Xu Zifu gave great recognition to the company's main products and production operations. Xu Zifu pointed out that during the current new crown pneumonia epidemic, the state has issued a series of preferential policies to support the development of private enterprises, especially in terms of capital loans. Stellite must make good use of it. Xu Zifu said that in the future production and operation process of Stellite, if it encounters problems and needs related to capital flow, foreign exchange settlement, etc., it can seek help from local financial departments. After the meeting, Xu Zifu and his party also visited the honor hall of the company.